Palovarotene decreases extracellular matrix Alcian blue staining
Cell-based study · growth plate chondrocytes were isolated from P3 ribs and sterna [1]
Growth plate chondrocytes isolated from ribs and sterna were treated with 50 nM Palovarotene added to the culture medium. Alcian blue staining of the extracellular matrix decreased significantly compared with vehicle control cultures.
| Endpoint | Reported result | Reference |
|---|---|---|
| Alcian blue staining of the extracellular matrix | Reported result Day 4 and day 7; palovarotene (50 nM): significant drop in Alcian blue staining of the extracellular matrix compared with vehicle control cultures. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 50 nM
- Exposure duration
- Starting on day 1; Fresh medium and drug were given every other day; Cultures were harvested on days 4 and 7
- Method
- added to the culture medium
- Co-treatment
- Other interventions in this design: beta‐glycerophosphate; ascorbic acid. Compound effect isolated by the comparison: compared with vehicle control cultures.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Palovarotene
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Preparation, treatment, and analysis of growth plate chondrocyte cultures (S66, S67); Results > Palovarotene does not reduce Inhba expression in chondrogenic cells in vitro (S148, S149, S150); Fig. 8 legend (S194)
Alcian blue staining of the extracellular matrix: Alcian blue staining of the extracellular matrix; comparator: vehicle control cultures — Results > Palovarotene does not reduce Inhba expression in chondrogenic cells in vitro (S150); Fig. 8 legend (S194)